• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

FK866 的 NAMPT 抑制剂的活性氧敏感前药的合成与评价。

Synthesis and Evaluation of Reactive Oxygen Species Sensitive Prodrugs of a NAMPT Inhibitor FK866.

机构信息

Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University, 393 Middle Huaxia Road, Pudong, Shanghai 201210, China.

School of Physical Science and Technology, ShanghaiTech University, 393 Middle Huaxia Road, Shanghai 201210, China.

出版信息

Molecules. 2022 Dec 25;28(1):169. doi: 10.3390/molecules28010169.

DOI:10.3390/molecules28010169
PMID:36615364
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9821821/
Abstract

NAMPT is an attractive target in cancer therapy and numerous NAMPT inhibitors have been developed. However, the clinical activities of NAMPT inhibitors have displayed disappointing results in clinical trials for their dose-limiting toxicities. In this study, reactive oxygen species (ROS)-responsive prodrugs of a NAMPT inhibitor FK866 were designed and synthesized. A short synthesis method was developed to shield the activity of FK866 through a quaternary ammonium connection. Two prodrugs, with boronic acid as a responsive group to ROS, were prepared and one of the prodrugs also contained a fluorescence carrier. Both of the prodrugs released the active compound by the treatment of HO, and the biological evaluation showed that they exhibited a higher potency in cells with high levels of ROS. Moreover, prodrug had the ability to release FK866 and simultaneously induce the fluorescence activation under the stimulation of HO. This method has the potential to improve the therapeutic window of NAMPT inhibitors.

摘要

NAMPT 是癌症治疗中有吸引力的靶点,已经开发出许多 NAMPT 抑制剂。然而,由于其剂量限制毒性,NAMPT 抑制剂在临床试验中的临床活性令人失望。在这项研究中,设计并合成了 NAMPT 抑制剂 FK866 的活性氧(ROS)响应前药。通过季铵连接开发了一种短的合成方法来屏蔽 FK866 的活性。制备了两个前药,其中一个前药含有硼酸作为 ROS 的响应基团,另一个前药还含有荧光载体。两种前药都通过 HO 的处理释放出活性化合物,生物学评价表明它们在 ROS 水平高的细胞中表现出更高的效力。此外,前药 能够在 HO 的刺激下释放 FK866 并同时诱导荧光激活。这种方法有可能提高 NAMPT 抑制剂的治疗窗口。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ebb/9821821/37c7413efd23/molecules-28-00169-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ebb/9821821/d477b1ba02a4/molecules-28-00169-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ebb/9821821/c5578b0c0191/molecules-28-00169-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ebb/9821821/b9c96892258d/molecules-28-00169-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ebb/9821821/7ad7d02dceb7/molecules-28-00169-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ebb/9821821/65dee608ec48/molecules-28-00169-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ebb/9821821/06175d75ea79/molecules-28-00169-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ebb/9821821/4af4598c4a22/molecules-28-00169-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ebb/9821821/37c7413efd23/molecules-28-00169-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ebb/9821821/d477b1ba02a4/molecules-28-00169-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ebb/9821821/c5578b0c0191/molecules-28-00169-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ebb/9821821/b9c96892258d/molecules-28-00169-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ebb/9821821/7ad7d02dceb7/molecules-28-00169-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ebb/9821821/65dee608ec48/molecules-28-00169-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ebb/9821821/06175d75ea79/molecules-28-00169-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ebb/9821821/4af4598c4a22/molecules-28-00169-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ebb/9821821/37c7413efd23/molecules-28-00169-g007.jpg

相似文献

1
Synthesis and Evaluation of Reactive Oxygen Species Sensitive Prodrugs of a NAMPT Inhibitor FK866.FK866 的 NAMPT 抑制剂的活性氧敏感前药的合成与评价。
Molecules. 2022 Dec 25;28(1):169. doi: 10.3390/molecules28010169.
2
Clickable prodrugs bearing potent and hydrolytically cleavable nicotinamide phosphoribosyltransferase inhibitors.带有强效且可水解裂解的烟酰胺磷酸核糖基转移酶抑制剂的可点击前药。
Drug Des Devel Ther. 2018 Apr 24;12:987-995. doi: 10.2147/DDDT.S152685. eCollection 2018.
3
Inhibition of NAMPT markedly enhances plasma-activated medium-induced cell death in human breast cancer MDA-MB-231 cells.NAMPT 抑制显著增强了人乳腺癌 MDA-MB-231 细胞中血浆激活介质诱导的细胞死亡。
Arch Biochem Biophys. 2019 Nov 15;676:108155. doi: 10.1016/j.abb.2019.108155. Epub 2019 Oct 16.
4
High expression of NAMPT in adult T-cell leukemia/lymphoma and anti-tumor activity of a NAMPT inhibitor.NAMPT 在成人 T 细胞白血病/淋巴瘤中的高表达和 NAMPT 抑制剂的抗肿瘤活性。
Eur J Pharmacol. 2019 Dec 15;865:172738. doi: 10.1016/j.ejphar.2019.172738. Epub 2019 Oct 12.
5
Crystal structure-based comparison of two NAMPT inhibitors.基于晶体结构的两种 NAMPT 抑制剂的比较。
Acta Pharmacol Sin. 2018 Feb;39(2):294-301. doi: 10.1038/aps.2017.80. Epub 2017 Aug 31.
6
A pancreatic ductal adenocarcinoma subpopulation is sensitive to FK866, an inhibitor of NAMPT.胰腺导管腺癌亚群对烟酰胺磷酸核糖转移酶(NAMPT)抑制剂FK866敏感。
Oncotarget. 2016 Aug 16;7(33):53783-53796. doi: 10.18632/oncotarget.10776.
7
Auxiliary in vitro and in vivo biological evaluation of hydrogen peroxide sensitive prodrugs of methotrexate and aminopterin for the treatment of rheumatoid arthritis.过氧化氢敏感型甲氨蝶呤和氨蝶呤前药的体外和体内辅助生物学评价,用于治疗类风湿关节炎。
Bioorg Med Chem. 2020 Jan 15;28(2):115247. doi: 10.1016/j.bmc.2019.115247. Epub 2019 Dec 6.
8
Genomic and tumor biological aspects of the anticancer nicotinamide phosphoribosyltransferase inhibitor FK866 in resistant human colorectal cancer cells.FK866 作为一种新型烟酰胺磷酸核糖基转移酶抑制剂,在耐药的人结直肠癌细胞中的抗肿瘤及基因组学研究
Genomics. 2019 Dec;111(6):1889-1895. doi: 10.1016/j.ygeno.2018.12.012. Epub 2018 Dec 21.
9
Inhibitor of Nicotinamide Phosphoribosyltransferase Sensitizes Glioblastoma Cells to Temozolomide via Activating ROS/JNK Signaling Pathway.烟酰胺磷酸核糖转移酶抑制剂通过激活 ROS/JNK 信号通路增强胶质母细胞瘤细胞对替莫唑胺的敏感性。
Biomed Res Int. 2016;2016:1450843. doi: 10.1155/2016/1450843. Epub 2016 Dec 20.
10
Association of ABC Transporter With Resistance to FK866, a NAMPT Inhibitor, in Human Colorectal Cancer Cells.ABC 转运蛋白与 NAMPT 抑制剂 FK866 耐药性在人结直肠癌细胞中的关系。
Anticancer Res. 2019 Dec;39(12):6457-6462. doi: 10.21873/anticanres.13859.

引用本文的文献

1
Boronate-Based Bioactive Compounds Activated by Peroxynitrite and Hydrogen Peroxide.由过氧亚硝酸盐和过氧化氢激活的基于硼酸盐的生物活性化合物。
Redox Biochem Chem. 2024 Dec;10. doi: 10.1016/j.rbc.2024.100040. Epub 2024 Aug 14.
2
Inhibition of NAMPT by PAK4 Inhibitors.PAK4 抑制剂对 NAMPT 的抑制作用。
Int J Mol Sci. 2024 Sep 21;25(18):10138. doi: 10.3390/ijms251810138.

本文引用的文献

1
Addressing the Enzyme-independent tumor-promoting function of NAMPT via PROTAC-mediated degradation.通过 PROTAC 介导的降解来解决 NAMPT 的酶非依赖性肿瘤促进功能。
Cell Chem Biol. 2022 Nov 17;29(11):1616-1629.e12. doi: 10.1016/j.chembiol.2022.10.007. Epub 2022 Nov 1.
2
Development of a nitroreductase-dependent theranostic payload for antibody-drug conjugate.硝基还原酶依赖性治疗性有效载荷用于抗体药物偶联物的开发。
Bioorg Chem. 2022 Dec;129:106190. doi: 10.1016/j.bioorg.2022.106190. Epub 2022 Oct 6.
3
Review of various NAMPT inhibitors for the treatment of cancer.
用于治疗癌症的各种烟酰胺磷酸核糖转移酶(NAMPT)抑制剂的综述。
Front Pharmacol. 2022 Sep 7;13:970553. doi: 10.3389/fphar.2022.970553. eCollection 2022.
4
NAMPT-targeting PROTAC promotes antitumor immunity suppressing myeloid-derived suppressor cell expansion.靶向烟酰胺磷酸核糖转移酶(NAMPT)的蛋白水解靶向嵌合体(PROTAC)通过抑制髓源性抑制细胞的扩增来促进抗肿瘤免疫。
Acta Pharm Sin B. 2022 Jun;12(6):2859-2868. doi: 10.1016/j.apsb.2021.12.017. Epub 2021 Dec 31.
5
Updated Functional Roles of NAMPT in Carcinogenesis and Therapeutic Niches.烟酰胺磷酸核糖转移酶(NAMPT)在肿瘤发生和治疗微环境中的更新功能作用
Cancers (Basel). 2022 Apr 19;14(9):2059. doi: 10.3390/cancers14092059.
6
A Nicotinamide Phosphoribosyltransferase Inhibitor, FK866, Suppresses the Growth of Anaplastic Meningiomas and Inhibits Immune Checkpoint Expression by Regulating STAT1.烟酰胺磷酸核糖基转移酶抑制剂FK866通过调节信号转导和转录激活因子1(STAT1)抑制间变性脑膜瘤的生长并抑制免疫检查点表达。
Front Oncol. 2022 Apr 20;12:836257. doi: 10.3389/fonc.2022.836257. eCollection 2022.
7
The role of ROS in tumour development and progression.活性氧物质在肿瘤发生发展中的作用。
Nat Rev Cancer. 2022 May;22(5):280-297. doi: 10.1038/s41568-021-00435-0. Epub 2022 Jan 31.
8
Diazaborines Are a Versatile Platform to Develop ROS-Responsive Antibody Drug Conjugates*.二氮杂硼烷是一种多功能平台,可用于开发 ROS 响应型抗体药物偶联物*。
Angew Chem Int Ed Engl. 2021 Dec 1;60(49):25914-25921. doi: 10.1002/anie.202109835. Epub 2021 Nov 5.
9
Advances in NAD-Lowering Agents for Cancer Treatment.降低 NAD 水平的癌症治疗药物的研究进展。
Nutrients. 2021 May 14;13(5):1665. doi: 10.3390/nu13051665.
10
Reactive Oxygen Species (ROS)-Responsive Prodrugs, Probes, and Theranostic Prodrugs: Applications in the ROS-Related Diseases.活性氧(ROS)响应型前药、探针和治疗前药:在与 ROS 相关疾病中的应用。
J Med Chem. 2021 Jan 14;64(1):298-325. doi: 10.1021/acs.jmedchem.0c01704. Epub 2020 Dec 23.